KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Pfizer (PFE) over the last 15 years, with Q3 2025 value amounting to $2.4 billion.

  • Pfizer's Prepaid Assets fell 3883.27% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 3883.27%. This contributed to the annual value of $4.3 billion for FY2024, which is 1339.85% down from last year.
  • According to the latest figures from Q3 2025, Pfizer's Prepaid Assets is $2.4 billion, which was down 3883.27% from $2.7 billion recorded in Q2 2025.
  • Pfizer's 5-year Prepaid Assets high stood at $6.1 billion for Q4 2022, and its period low was $2.4 billion during Q3 2025.
  • Over the past 5 years, Pfizer's median Prepaid Assets value was $4.2 billion (recorded in 2022), while the average stood at $4.3 billion.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 6224.27% in 2022, then plummeted by 3883.27% in 2025.
  • Pfizer's Prepaid Assets (Quarter) stood at $3.8 billion in 2021, then skyrocketed by 31.34% to $5.0 billion in 2022, then decreased by 2.11% to $4.9 billion in 2023, then fell by 13.4% to $4.3 billion in 2024, then tumbled by 44.56% to $2.4 billion in 2025.
  • Its last three reported values are $2.4 billion in Q3 2025, $2.7 billion for Q2 2025, and $2.9 billion during Q1 2025.